Short answer · Medically reviewed summary · Last updated: 2026-04-07
Chronic Mucocutaneous Candidiasis (CMC) is a rare, hereditary condition caused by specific genetic mutations, whereas common yeast infections caused by Candida albicans are not considered hereditary. Understanding the Genetic Distinction It is vital to distinguish between sporadic, localized Candidiasis—which is an opportunistic fungal infection—and Chronic Mucocutaneous Candidiasis (CMC). While most people experience Candidiasis as a temporary infection due to external factors, individuals with CMC have an underlying primary immunodeficiency that makes them uniquely susceptible to persistent Candida infections of the skin, nails, and mucous membranes. Inheritance and Risk The inheritance of CMC depends on the specific gene involved, such as STAT1, IL-17F, or AIRE.
Chronic Mucocutaneous Candidiasis (CMC) is a rare, hereditary condition caused by specific genetic mutations, whereas common yeast infections caused by Candida albicans are not considered hereditary.
It is vital to distinguish between sporadic, localized Candidiasis—which is an opportunistic fungal infection—and Chronic Mucocutaneous Candidiasis (CMC). While most people experience Candidiasis as a temporary infection due to external factors, individuals with CMC have an underlying primary immunodeficiency that makes them uniquely susceptible to persistent Candida infections of the skin, nails, and mucous membranes.
The inheritance of CMC depends on the specific gene involved, such as STAT1, IL-17F, or AIRE. Mutations in STAT1 often follow an autosomal dominant pattern, meaning a child of an affected parent has a 50% chance of inheriting the mutation. Other forms, such as those related to APECED syndrome, follow an autosomal recessive pattern, where the risk to siblings is 25% if both parents are carriers. De novo mutations (spontaneous changes not present in parents) are documented in some STAT1 cases, though familial inheritance is more common in established pedigrees.
Genetic testing is recommended for patients presenting with recurrent, recalcitrant Candidiasis that does not respond to standard antifungal treatments. A clinical geneticist can guide families through panel testing to identify specific variants. For those planning a pregnancy, genetic counseling provides clarity on recurrence risks and discusses options such as preimplantation genetic testing (PGT) if a pathogenic variant is identified. Because the clinical presentation of CMC varies significantly even within families, professional genetic counseling is essential to navigate the complexities of these immune-related, inherited forms of Candidiasis.
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult with your physician or a qualified genetic specialist regarding your specific health concerns or family medical history.